AXIM Biotechnologies (AXIM) 8-K Changes in Registrant's Certifying Accountant

Exhibit 16.1

SECURITIES AND EXCHANGE COMMISSION

Division of Corporation Finance

100 F Street, N.E., Mail Stop 7010

Washington, D.C. 20549

Re:           AXIM International, Inc. (the “Company”)

Form 8-K, Item 4.01, dated May 14, 2014 (the “Report”)

Gentlemen:

We have reviewed the above referenced Report filed by the Company.  We agree with the statements made by the Company in the Report and authorize the Company to file a copy of this letter as an exhibit to the Report.

Jeffrey & Company

/s/ Jeffrey & Company

Wayne, New Jersey

May 16, 2014